Status:
COMPLETED
Evaluation of Symptoms, Complications and Side Effects of Adding Medications Continuously To Subcutaneous Infusion (Hypodermoclysis) In Home Care Hospice Patients
Lead Sponsor:
Soroka University Medical Center
Collaborating Sponsors:
Ben-Gurion University of the Negev
Conditions:
Home Infusion Therapy
Infusion Pumps
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Terminal patients are often unable to swallow and need medications to control symptoms. In these cases medications are administered continuously and subcutaneously by a syringe driver. A s...
Eligibility Criteria
Inclusion
- Patients in the home care unit that need medication/s continuously subcutaneously with symptoms level of 6 or higher on a visual analogue scale (VAS) for that symptom.
Exclusion
- Patients and caregivers that refuse to participate.
- Every occasion when the infusion period will be less than 48 hours.
- Every occasion when the patient and/or main care giver are not able to provide reliable information by the judgment of the medical staff person or research worker.
- Patients that will need other medications subcutaneously that are not included in the study during their study treatment period.
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2007
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00320866
Start Date
February 1 2002
End Date
December 1 2007
Last Update
April 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ben-Gurion University of the Negev Sial Research Center for Family Medicine and Primary Care
Beersheba, Israel, 653